Patients with chronic kidney disease (CKD) need to avoid drugs with potential renal toxicity and CKD-stage contraindications. However, certain potentially harmful drugs such as benzodiazepines, opioids, antipsychotics, mood stabilizers may evade such classifications. Real-world evidence from Japan on prescribing patterns of such potentially harmful drugs and their association with kidney function decline remains limited.
Momo et al. (Wed,) studied this question.